Taking Action from RWE Analytics: Use of Health Insights Dataset Reveal Underdiagnosis and Care Gaps in NASH and NAFLD
Excerpt of tHEORetically Speaking blog post sponsored by Veradigm Nonalcoholic fatty liver disease (NAFLD), including the more aggressive NASH (nonalcoholic [...]
ISPOR Seeks New Members for Health Science Policy Council
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is searching for three mid-career members for its Health Science Policy [...]
On-Demand Webinar Offers Guidance for Getting Started in MedComms
A recent webinar hosted by NetworkPharma.tv offers guidance for individuals interested in entering a career in the medical communications landscape. [...]
Rubenstein Talks Modern RWD, RWE in Regulatory Decision-Making
FDA Center for Devices and Radiological Health Director of Personalized Medicine Wendy Rubenstein says modern sources of real-world evidence and [...]
FDA Rejects Intercept’s OCA for NASH
The Food and Drug Administration (FDA) last month rejected Intercept Pharmaceuticals' nonalcoholic steatohepatitis (NASH) drug, creating a major delay in [...]
Opinion: Discuss Price for COVID-19 Vaccine Now, Not Later
The U.S. should begin pricing discussions for a COVID-19 vaccine before we get "stuck paying dearly for shots that the [...]
Report Explores Patient Centricity in Clinical Trials
A new report by the Economist Intelligence Unit explores the importance of expanding patient engagement in the clinical trial landscape. [...]
ICER Hosting Series on Drug Pricing During a Pandemic
The Institute for Clinical and Economic Review (ICER) is scheduled to host a three-part series focused on drug pricing during [...]
Article: Researchers Point to Germany’s Model for Purchasing Cancer Drugs
Researchers say U.S. policymakers should look to Germany's drug purchasing model to try and better align cancer drug prices with [...]
ICER Reschedules CF Meeting
The Institute for Clinical and Economic Review (ICER) has rescheduled its public meeting on cystic fibrosis treatments to Aug. 27. [...]
NPC Webinar on COVID-19 Prices Nears
The National Pharmaceutical Council's webinar on COVID-19 drug prices is less than a week away. Registration for the event remains [...]
NICE Clinical Fellow Ali Highlights Sustainability Efforts
Fizzah Ali, a medical clinical fellow at the U.K.'s National Institute for Health and Care Excellence, discusses how the Sustainability [...]
ISPOR to Host Webinar on Drug, Device Utilization Amid Pandemic
The International Society for Pharmacoeconomics and Outcomes Research is set to host a July 28 webinar highlighting the COVID-19 pandemic's [...]
Medidata, CTI Partner on Remote Trial Reviews
CTI Clinical Trial Solutions and Consulting Services is partnering with Medidata to facilitate remote monitoring and reviews for clinical trials [...]
Report: European Drug Regulatory Network Faces Uncertain, Complex Future
A new strategy produced by European regulators considers future challenges for the European drug regulatory network, The Pink Sheet reports. [...]
ICER Outlines Planned Review of High Cholesterol Treatments
The Institute for Clinical and Economic Review (ICER) in a recently-released document outlines its planned review of high cholesterol treatments. [...]
NPC, Duke-Margolis Center for Health Policy Name New Health Policy Fellow
The National Pharmaceutical Council (NPC) and Duke-Margolis Center for Health Policy recently named Salama Freed as the 2020-22 post-doctoral health [...]
IFAPP Academy, MAPS Offer Medical Affairs Course
IFAPP Academy and the Medical Affairs Professional Society (MAPS) are offering an online course for medical affairs professionals looking to [...]
Measuring Care Value
Stacey Richter, Relentless Health Value host and Aventria Health Group co-founder, discusses metrics for measuring care value in the latest [...]
Capital Rx CEO Talks Price Transparency
Capital Rx CEO A.J. Loiacono in a new Patients Rising Podcast discusses the importance of price transparency at the pharmacy [...]
Cytel COVID-19 Clinical Development Quiz
Cytel is offering a quiz for users to gauge their knowledge on the state of COVID-19 clinical development across the [...]
OptumRx’s Calabrese: Top 3 Drugs in Pipeline
OptumRx Senior Vice President and Chief Pharmacy Officer David Calabrese in a recent interview with Managed Healthcare Executive discusses the [...]
ACS Researchers Receive RWD Award
Three American Cancer Society researchers have been awarded the Real-World Data Impact Award, ACS and Flatiron Health announced this week. [...]
McClellan Stresses Need for RWE Infrastructure
Duke-Margolis' Mark McClellan tells The Pink Sheet a robust real-world evidence infrastructure is needed, and that RWE studies should be [...]
Gupta: Five Trends That Have Accelerated in 2020
Heron Therapeutics' Anita Gupta in a recent piece published on Forbes highlights five key trends that have accelerated during the [...]